canada semaglutide patent expiry approves generic from Dr. Reddy's, a G7 first enabled by Novo Nordisk's lapsed CAD$250 Cheaper GLP-1s arrive in Canada:

Tirzepatide (Mounjaro), a newer dual GIP/GLP-1 receptor agonist, is also available in the UK, though it may also cause gastrointestinal side effects

Research indicates that an imbalance in this important neurotransmitter can also contribute to serious problems like depression, obsessive compulsive disorder, anxiety, post-traumatic stress disorder and even epilepsy

If your mitochondria have been starved of fatty acid fuel due to carnitine insufficiency, or your metabolic enzymes have been operating without adequate B vitamin cofactors, correcting these deficiencies should produce noticeable results

Semaglutide is FDA-approved for managing obesity and overweight conditions with related health risks